| Identification | Back Directory | [Name]
YM90Khydrochloride | [CAS]
154164-30-4 | [Synonyms]
YM 90K
CS-885
YM-90K HCL
YM90Khydrochloride
6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-
6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione
1,4-Dihydro-6-(1H-imidazol-1-yl)-7-nitro-2,3-quinoxalinedionehydrochloride
1,4-Dihydro-6-(1H-imidazol-1-yl)-7-nitro-2,3-quinoxalinedione monohydrochloride
2,3-Quinoxalinedione,1,4-dihydro-6-(1H-imidazol-1-yl)-7-nitro-,monohydrochloride
2,3-Quinoxalinedione,1,4-dihydro-6-(1H-imidazol-1-yl)-7-nitro-, hydrochloride (1:1) | [Molecular Formula]
C11H7N5O4.HCl | [MDL Number]
MFCD00912163 | [MOL File]
154164-30-4.mol |
| Hazard Information | Back Directory | [Uses]
YM 90K Hydrochloride is a selective AMPA receptor antagonist. | [Biological Activity]
Selective AMPA receptor antagonist (K i values are 84, 2200 and > 37000 nM for AMPA, kainate and NMDA receptors respectively). Neuroprotective; delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration. | [in vivo]
YM90K shows potent suppressive activity against audiogenic seizure in DBA/2 mice; ED50 values of YM90K against tonic seizure is 2.54 mg/kg (i.p.). The duration of the anticonvulsant effects of YM90K is 30 min[1].
In a global ischemia model, YM90K (15 mg/kg i.p.) significantly prevents the delayed neuronal death in the hippocampal CA1 region in Mongolian gerbils when administered 1 h after 5-min ischemia. The therapeutic time window for the neuroprotective effect of YM90K (30 mg/kg i.p.) is 6 h[1].
In a focal ischemia model, YM90K (30 mg/kg i.v. bolus+10 mg/kg/h for 4 h) reduces the volume of ischemic damage in the cerebral cortex in F344 rats[1].
| [storage]
Desiccate at RT |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
400-0056266 |
| Website: |
www.energy-chemical.com |
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|